Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-25

Proteomics approaches to identify new vaccine candidates against group B Streptococcus

Objective

During the last century, several approaches have been used for the development of vaccines, ranging from the immunization with live-attenuated bacteria up to the formulation of the safer sub-unit vaccines. These conventional approaches to vaccine development require cultivation of the pathogen and its dissection using biochemical, immunological and microbiological methods. Although successful in several cases, these methods have failed to provide solutions against many human pathogens. With the impressive progress of bio informatics and high throughput protein expression, three new areas, genomics, transcriptomics, and proteomics, have emerged with the potential to enormously speed up the vaccine discovery process. Each of these approaches leads to the selection of the most relevant proteins for the induction of protective immune responses, e.g. membrane-associated proteins, secreted proteins and virulence factors. Genomic involves the sequencing of a given bacterial genome and the use of various algorithms to predict which genes potentially code for membrane-associated and virulence-associated proteins. Transcriptomics is of particular interest to define virulence factors. It uses DNA micro arrays to measure bacterial gene expression in response to host/pathogen interaction. Proteomics allows the direct identification of potential vaccine candidates through the separation of bacterial membrane-associated proteins (usually by two-dimensional electrophoresis), and the iridentification by mass spectrometry.
Once selected, the potential vaccine candidates are expressed and purified in a high throughput setting and the purified antigens are finally tested in correlate-of-protection assays to select the most promising vaccine candidates. The availability of a large collection of bacterial proteins also allows the identification of most immunogenic antigens using protein microarray technology.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2002-MOBILITY-5
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

EIF - Marie Curie actions-Intra-European Fellowships

Coordinator

CHIRON S.R.L.
EU contribution
No data
Address
Via Fiorentina, 1
SIENA
Italy

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0